Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
23.02
-0.46 (-1.96%)
At close: May 8, 2026, 4:00 PM EDT
23.10
+0.08 (0.35%)
After-hours: May 8, 2026, 6:56 PM EDT
Tango Therapeutics Employees
Tango Therapeutics had 137 employees as of December 31, 2025. The number of employees decreased by 18 or -11.61% compared to the previous year.
Employees
137
Change (1Y)
-18
Growth (1Y)
-11.61%
Revenue / Employee
$455,358
Profits / Employee
-$741,562
Market Cap
3.32B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 137 | -18 | -11.61% |
| Dec 31, 2024 | 155 | 15 | 10.71% |
| Dec 31, 2023 | 140 | 30 | 27.27% |
| Dec 31, 2022 | 110 | 19 | 20.88% |
| Sep 30, 2022 | 109 | 26 | 31.33% |
| Jun 30, 2022 | 103 | 17 | 19.77% |
| Mar 31, 2022 | 98 | 21 | 27.27% |
| Dec 31, 2021 | 91 | 14 | 18.18% |
| Sep 30, 2021 | 83 | 6 | 7.79% |
| Jun 30, 2021 | 86 | - | - |
| Mar 31, 2021 | 77 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| ACADIA Pharmaceuticals | 798 |
| Arcus Biosciences | 601 |
| Beam Therapeutics | 511 |
| Denali Therapeutics | 503 |
| Dyne Therapeutics | 258 |
| Alumis | 224 |
| Catalyst Pharmaceuticals | 182 |
TNGX News
- 5 days ago - Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 13 days ago - Tango Therapeutics price target raised to $40 from $24 at Stifel - TheFly
- 25 days ago - Tango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of Vopimetostat - GlobeNewsWire
- 5 weeks ago - Canaccord starts Tango Therapeutics with Buy on PRMT5 inhibitor - TheFly
- 5 weeks ago - Tango Therapeutics initiated with a Buy at Canaccord - TheFly
- 6 weeks ago - Tango Therapeutics price target raised to $21 from $14 at B. Riley - TheFly
- 2 months ago - Tango Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Tango Therapeutics price target raised to $20 from $19 at Mizuho - TheFly